Serum VDBP levels might be an individual marker of disease development, independent of age, menopausal status, nature of symptoms, tuberous sclerosis, angiomyolipoma, lymphatic disease, or serum VEGF-D levels. This evidence concerns the gene VEGFD and tuberous sclerosis.